MED - NYSE
Medifast, Inc.
$12.24
-0.61%Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
At a Glance
Live SnapshotMedifast, Inc. Management Team
Mr. Anthony E. Tyree
Chief Business Operations Officer
Compensation
$573,773
Mr. Nicholas M. Johnson
Chief Field Operations Officer
Compensation
$607,517
Mr. James P. Maloney CPA
Chief Financial Officer
Compensation
$724,148
Ms. Claudia C. Greninger
Chief Human Resources Officer
Mr. Daniel R. Chard
Executive Chairman & Chief Executive Officer
Compensation
$1,580,186
Mr. Jason L. Groves Esq.
Executive Vice President, General Counsel & Corporate Secretary
Compensation
$588,859
Mr. Jonathan Barrett MacKenzie
Vice President of Finance & Chief Accounting Officer
Mr. Steven Zenker
Vice President of Investor Relations
Medifast, Inc. Insider Positioning
During the last 12 months, insiders have purchased $247K worth of MED shares, with no selling activity reported.
3 Months
22.7K
241.67K
0
0.00
+242K
+$242K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
381
5.00K
0
0.00
+5K
+$5K
Top Buyers
Chard Daniel R
Director, Officer: Chairman & Ceo
$184K
Schlackman Scott
Director
$63K
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $247K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
2 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
SEC Filings
MED - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 06, 2026 | May 19, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 29, 2025 | June 18, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 26, 2024 | June 19, 2024 | 2024 | |
DEF 14A DEF 14A N/A | May 01, 2023 | May 01, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 21, 2022 | June 15, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 15, 2021 | June 02, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 28, 2020 | June 15, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 22, 2019 | June 12, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 30, 2018 | June 13, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 07, 2017 | May 18, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.